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1  | INTRODUC TION
Oral autoimmune bullous disorders (OABD), including mucous mem‐
brane pemphigoid (MMP), pemphigus vulgaris (PV), paraneoplas‐
tic autoimmune multiorgan syndrome/paraneoplastic pemphigus 
(PAMS/PNP), and others, can show considerable clinical overlap 
with diseases such as oral lichen planus (OLP) and other disorders 
that may cause desquamative or erosive gingivitis and oral ulcers 
(Yih, Maier, Kratochvil, & Zieper, 1998). Although conventionally six 
patterns of OLP are recognized (Cheng, Gould, Kurago, Fantasia, & 
Muller, 2016), clinically, only three are readily distinguishable: hyper‐
keratotic/reticular (Figure 1), erythematous/erosive/atrophic, and 
ulcerative (Park, Hurwitz, & Woo, 2012). A bullous pattern has been 
described but is rarely seen, as oral bullae rupture due to trauma, 
forming erythematous/erosive lesions. OLP typically involves the 
buccal mucosa, gingiva, and tongue in a bilateral and symmetric 
fashion. When OLP presents with involvement of the gingiva or 
with a predominantly ulcerative or erosive pattern (Figure 2), the 
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Abstract
Objectives: Oral autoimmune bullous disorders show clinical overlap with diseases 
such as lichen planus and others that may cause desquamative gingivitis. As direct 
immunofluorescence is expensive, we sought to determine if routine histology alone 
would be sufficient to distinguish between oral autoimmune bullous disorders and 
mimics.
Methods: We searched the records for patients with a suspected oral autoimmune 
bullous disorder who underwent biopsies for concurrent routine histologic evalua‐
tion and direct immunofluorescence and who had at least one follow‐up visit. Cases 
were separated into high and low suspicion subgroups based on clinical findings.
Results: Within 148 cases, the sensitivity of routine histology alone was 0.810, with 
a negative predictive value of 0.889. However, the specificity was 0.989 with a posi‐
tive predictive value of 0.979. Of the high suspicion cases, 57 (47.1%) were found to 
be consistent with an oral autoimmune bullous disorder, with a total of 11 histologic 
false negatives. 8 cases, all in the high suspicion subgroup, showed indeterminate 
direct immunofluorescence results. There were no histologic false negatives or in‐
conclusive direct immunofluorescence results in the low suspicion subgroup.
Conclusions: In patients with a low clinical suspicion for an oral autoimmune bullous 
disorder, it is reasonable and more cost‐effective to evaluate the lesion with routine 
histology alone.
K E Y W O R D S
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differential diagnosis can include OABD such as MMP (Figure 3) and 
PV (Figure 4). Furthermore, OLP and OABD occur in similar patient 
populations, namely females in the sixth and seventh decades of life 
(Laskaris, Sklavounou, & Angelopoulos, 1982; Laskaris, Sklavounou, 
& Stratigos, 1982). Although the symptoms and signs of OLP and 
MMP can often be controlled with topical corticosteroids, individu‐
als with PV invariably require systemic therapy (Heelan et al., 2014; 
Lamey et al., 1992; Sultan, Villa, Saavedra, Treister, & Woo, 2017). 
Additionally, patients with the cicatricial variant of MMP frequently 
develop ocular involvement (Messmer, Hintschich, Partscht, Messer, 
& Kampik, 2000), and accurate diagnosis is critical to prevent serious 
sequelae such as loss of vision.
Both cutaneous and OLP exhibit characteristic changes on 
routine histology including hyperkeratosis or parakeratosis, ac‐
anthosis or atrophy, vacuolar change of the basal epithelial layer, 
“saw‐tooth” rete ridges, Civatte bodies, and a lymphocytic band 
at the interface (Figure 5). Sub‐epithelial clefting is often noted in 
OLP,	often	termed	the	Max‐Joseph	space	 (Aminzadeh,	Jahanshahi,	
& Ahmadi, 2013), and may mimic MMP, and DIF is helpful in such 
cases. Other lichenoid processes, such as lichenoid drug reaction 
F I G U R E  1   Oral lichen planus exhibiting well‐formed buccal 
reticulation [Colour figure can be viewed at wileyonlinelibrary.com]
F I G U R E  2   Oral lichen planus presenting as diffuse 
desquamative gingivitis but with reticulation visible in the posterior 
third of the left cheek as well as the vestibular maxillary gingiva 
[Colour figure can be viewed at wileyonlinelibrary.com]
FIGURE 3 Pemphigus vulgaris exhibiting diffuse bullae, 
ulceration, and erythema [Colour figure can be viewed at 
wileyonlinelibrary.com]
F I G U R E  4   Mucous membrane pemphigoid presenting as 
diffuse desquamative gingivitis [Colour figure can be viewed at 
wileyonlinelibrary.com]
F I G U R E  5   Characteristic histology of lichen planus includes 
hyperkeratosis, acanthosis (some cases show atrophy), “saw‐tooth” 
rete ridges, basal cell degeneration, Civatte bodies, and a band of 
lymphocytes at the interface (H&E, ×100) [Colour figure can be 
viewed at wileyonlinelibrary.com]
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or contact‐mediated lichenoid hypersensitivity reactions, chronic 
graft‐versus‐host disease (cGVHD), lupus erythematosus (LE), and 
others can show histologic overlap with OABD. Furthermore, histo‐
logic patterns on standard hematoxylin and eosin (H&E) sections can 
be non‐specific or subtle in many cases of OABD.
For these reasons, it is commonly accepted that cases suspicious 
for OABD require DIF for definitive diagnosis, and OLP and other 
lichenoid processes exhibit a non‐specific pattern of DIF, ruling out 
OABD. In fact, the presence of specific immune deposits at the base‐
ment membrane zone is considered a major diagnostic criterion for 
MMP (Chan et al., 2002). Additionally, a positive DIF result or the 
serological detection of autoantibodies directed against epithelial 
surface antigens is considered necessary for a diagnosis of pem‐
phigus (Murrell et al., 2018). In the current environment of growing 
demand to curb increases in healthcare costs while upholding high 
standards of patient care, we sought to determine if hematoxylin and 
eosin (H&E) evaluation alone would, in selected cases, be sufficient 
to distinguish between OABD and clinical mimics, keeping in mind 
that definitive characterization is sometimes more reliably arrived at 
from the clinical presentation and subsequent follow‐up.
2  | MATERIAL S AND METHODS
This retrospective study was approved by the Brigham and Women's 
Hospital (BWH) Institutional Review Board (protocol number 
201700010) and was performed in accordance with the Declaration 
of Helsinki. We searched the BWH pathology records for patients 
with suspected OABD who underwent biopsies for concurrent H&E 
and DIF studies and who had at least one follow‐up visit at our hospi‐
tal during the period from 1993 to 2016. Cases that had insufficient 
tissue, such as the lack of epithelium on either the H&E or DIF prepa‐
ration, were excluded. Upon review of the medical record, cases 
were separated into high suspicion (HS) and low suspicion (LS) sub‐
groups based on clinical findings. Physical examination findings were 
recorded as the presence of reticulation, erythema, or ulceration, 
or a combination of the three, and any additional descriptors such 
as bullae or vesicles. Criteria for LS and HS cases are presented in 
Table 1. HS cases included those with either desquamative gingivitis 
or mucosal ulceration without evidence of reticulation (for additional 
criteria see Table 1). Patients needed to only satisfy one criterion in 
either the low clinical suspicion or high clinical suspicion categories 
to qualify for the respective group. Specifically, if a patient presented 
with clinical findings and history consistent with classic oral lichen 
planus or recurrent aphthous stomatitis, and/or had concomitant dis‐
eases associated with either condition, that patient was considered 
to be in the low suspicion group. Alternatively, if a patient's physical 
examination revealed either desquamative gingivitis or oral ulcers 
not consistent with oral lichen planus or RAS and/or there were mu‐
cocutaneous signs and symptoms concerning for MMP, PV, or PNP/
PAMS, they were deemed to be highly suspicious for OABD.
On routine H&E evaluation, cases were diagnosed as compatible 
or characteristic of OABD or not compatible with OABD based on 
commonly accepted criteria. For example, PV characteristically shows 
suprabasal acantholysis and intraepithelial blister formation (Figure 6). 
MMP classically causes a subepithelial split with preservation of basal 
cells that can often be quite subtle (Figure 7). DIF findings were cate‐
gorized as either diagnostic of OABD, negative for a specific pattern 
of immunoreactivity, or inconclusive. Characteristic patterns of DIF 
included linear deposition of IgG and/or C3 along the basement mem‐
brane zone (BMZ) for MMP and a fish net‐like pattern of intercellular 
IgG and C3 within the epithelium for PV. A definitive diagnosis was 
then assigned to the patient based on biopsy results, DIF, correlation 
with clinical findings, laboratory results (including indirect immuno‐
fluorescence), and, in some cases, re‐biopsy. Sensitivity, specificity, 
positive predictive value, and negative predictive value of H&E tissue 
examination were then calculated based on standard 2 × 2 contin‐
gency tables within the LS and HS subgroups for cases that were de‐
finitively classified as OABD or non‐OABD (all but one case). Values 
for all cases regardless of clinical suspicion were also calculated.
TA B L E  1   Criteria used to determine level of suspicion for OABD
Low clinical suspicion High clinical suspicion
Bilateral, symmetric reticulation 
with or without erythema and 
ulceration (consistent with OLP)
Concomitant diseases associated 
with oral lichenoid lesions, such 
as LE
1–5 discrete ulcers, <1 cm, with a 
clinical history of episodic ulcers 
since childhood (consistent with 
RAS)
Concomitant diseases associated 
with RAS, such as Crohn disease
Desquamative gingivitis with‐
out reticulation
Focal or multifocal ulceration 
without reticulation
Intact or collapsed bulla(e) 
present without reticulation
Mucocutaneous signs and 
symptoms (e.g., ocular, nasal, 
genital involvement) sugges‐
tive of MMP, PV, or PNP/
PAMS
Abbreviations: LE, lupus erythematosus; MMP, mucous membrane pem‐
phigoid; OLP, oral lichen planus; PAMS/PNP, paraneoplastic autoim‐
mune multiorgan syndrome/paraneoplastic pemphigus; PV, pemphigus 
vulgaris; RAS, recurrent aphthous stomatitis.
F I G U R E  6   Characteristic histopathology of pemphigus vulgaris 
demonstrating suprabasal acantholysis (H&E, ×100) [Colour figure 
can be viewed at wileyonlinelibrary.com]
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3  | RESULTS
There were 148 cases, with a mean age of 56 years (Table 2); there 
were 103 females (69.6%) and 45 males (30.4%). One hundred and 
thirty‐three patients were definitively diagnosed based on H&E his‐
topathology, DIF, and clinical presentation. The most common di‐
agnoses were OLP or lichenoid hypersensitivity reaction (47), MMP 
(27), and PV (26). Of the 15 cases that did not receive a definitive 
diagnosis, 14 cases were determined to be non‐OABD by DIF re‐
sults. In the one remaining case, the differential diagnosis was either 
cGVHD or PAMS/PNP in a patient with a history of chronic lympho‐
cytic leukemia status post‐allogeneic bone marrow transplantation. 
In this case, DIF showed a pattern of intercellular deposition of IgG, 
but none within basement membrane zone.
There were 27 LS and 121 HS cases (Table 3). In the LS sub‐
group, just one case had a positive DIF study that was interpreted on 
H&E as non‐specific chronic inflammation with eosinophils and focal 
subepithelial clefting, raising suspicion for MMP. DIF showed strong 
linear IgG and C3 along the BMZ, consistent with MMP. As focal 
findings characteristic of MMP were indeed present in this case, it 
was considered to be a true positive histologic result. Of the 26 re‐
maining cases in the LS subgroup, H&E evaluation was inconsistent 
with OABD and DIF studies were all negative for specific immune 
deposits. Of these cases, 14 of 26 were assigned a definitive diagno‐
sis of OLP or lichenoid hypersensitivity reaction. Two of these cases 
were associated with systemic lupus erythematosus (SLE; Table 3). 
Although OLP‐like lesions can be seen as a manifestation of SLE, 
characteristic findings of lupus were not seen on DIF in either case. 
One additional case was diagnosed as recurrent aphthous stomatitis 
(RAS) associated with Crohn disease. Two cases were diagnosed as 
cGVHD. Seven additional cases were assigned a definitive diagno‐
sis (after correlation with clinical findings, other clinical tests, and 
consideration of pathology reports and other laboratory data) that 
included various entities (Table 3). The two remaining cases were 
not assigned a final diagnosis but were considered to be non‐OABD.
Of the HS cases, 57 of 121 (47.1%) were found to be consistent 
with OABD. This included 26 cases of MMP and 26 cases of PV. There 
were three cases of PAMS/PNP, two of which were associated with 
chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/
SLL), and one with a gastrointestinal neuroendocrine tumor. There was 
one case of pemphigoid gestationis and one case of linear IgA disease; 
both patients had skin lesions in addition to oral lesions. Importantly, 
F I G U R E  7   Mucous membrane pemphigoid showing 
preservation of the basal cells and subtle subepithelial clefting 
(H&E, ×100) [Colour figure can be viewed at wileyonlinelibrary.com]
TA B L E  2   Demographic information of the patient cohort separated into OLP and other non‐OABD cases, OABD cases, and those with 
an undetermined diagnosis
 




Number of cases 75 58 14 1 148
Average age (y) 55 56 53 76 56
Number female 58 (77.3%) 38 (65.5%) 7 (50.0%) 0 (0%) 103 (69.6%)
Number male 17 (22.7%) 20 (34.5%) 7 (50.0%) 1 (100%) 45 (30.4%)
Number LS 24 1 2 0 27
Number HS 51 57 12 1 121
Definitive diagnosis 47 OLP 27 MMP n/a cGVHD versus PNP/PAMS  
13 RAS 26 PV
2 cGVHD 3 PNP/PAMS
2 EM 1 PG
11 othera 1 linear IgA
Abbreviations: cGVHD, chronic graft‐versus‐host disease; EM, erythema multiforme; HS, high suspicion; LS, low suspicion; MMP, mucous membrane 
pemphigoid; OABD, oral autoimmune bullous disorder; OLP, oral lichen planus; PG, pemphigoid gestationis; PNP/PAMS, paraneoplastic pemphigus/
paraneoplastic autoimmune multiorgan syndrome; PV, pemphigus vulgaris; RAS, recurrent aphthous stomatitis.
aOther	diagnosis	included	plasma	cell	gingivitis,	exfoliative	cheilitis,	hyperkeratosis	not	otherwise	specified,	osteonecrosis	of	the	jaw	(ONJ)	present‐
ing with erythematous gingiva, squamous cell carcinoma, crohn disease, methotrexate stomatitis, autoimmune progesterone dermatitis, desquama‐
tive gingivitis in the setting of celiac disease, gingivitis (periodontal disease), and herpes simplex virus infection. 
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within this group of definitive OABD cases that were HS lesions, there 
were seven cases that initially showed indeterminate DIF results, 
namely weak or focal staining that was insufficient for a diagnosis of 
OABD. However, based on the clinical presentation and follow‐up, 
and in some cases re‐biopsy, these cases were eventually diagnosed 
as MMP (three cases), PAMS/PNP (two cases) and PV (one case). In the 
remaining case, the diagnosis was equivocal and the differential diag‐
nosis included chronic GVHD and PAMS/PNP. In terms of histologic 
diagnosis, although one report showed squamous mucosa with no 
specific pathologic change, most biopsies showed non‐specific chronic 
inflammation with no significant changes in the overlying epithelium.
Of the 50 non‐OABD HS cases, 33 were diagnosed as OLP or li‐
chenoid hypersensitivity reaction (one being to cinnamic aldehyde), 
one with associated conjunctival scarring; this patient had scarring 
OLP confirmed with conjunctival biopsy with DIF studies. Twelve 
HS cases were diagnosed as non‐specific ulcers consistent with RAS 
and two cases were diagnosed as erythema multiforme. The remain‐
ing four cases were assigned miscellaneous non‐OABD diagnoses 
(Table 3), including autoimmune progesterone dermatitis, which does 
not form bullae, and typically shows non‐specific DIF findings but with 
specific antibodies detectable by indirect immunofluorescence (Farah 
& Shbaklu, 1971; Lee, Yoon, Yi, & Cho, 1992). Thirteen additional cases 
were not assigned definitive diagnoses, even after clinical correlation 
and reviewer evaluation; however, 12 of these were considered to be 
non‐OABD. One of the non‐OABD HS cases showed indeterminate 
DIF results and was eventually diagnosed as OLP.
Altogether, there were 11 H&E and 6 DIF false negatives, all in the 
HS subgroup (Table 4). In two of six latter cases, the H&E diagnosis 
was consistent with MMP, namely subepithelial clefting with preser‐
vation of basal cells and minimal inflammation. In the remaining four 
cases, the diagnosis of OABD was confirmed clinically or by repeat 
biopsy—two cases of MMP, the one case of pemphigoid gestationis, 
and one case of PV. There was one H&E false positive, which was in 
the high suspicion group due to the absence of reticulation on exam. 
This was a patient whose histology showed squamous mucosa with 
hyperparakeratosis and interface stomatitis without acantholysis. As 
there was some subepithelial separation, it was noted that the findings 
could represent bullous lichen planus or pemphigoid. However, DIF 
was negative for specific immune deposits.
In summary, the sensitivity of H&E alone (using a summative 
total of clinical presentation, follow‐up, and DIF as the gold stan‐
dard) was just 0.810 (Table 5), with a negative predictive value of 
0.889. However, H&E findings were highly specific (0.989) with a 
high positive predictive value (0.979).
Definitive diagnosis Low clinical suspicion High clinical suspicion





Linear IgA 0 1




OLP 14 (2 associated with SLE) 33
RAS 1 (associated with CD) 12
cGVHD 2 0
EM 0 2
Other 7 (plasma cell gingivitis, exfolia‐
tive cheilitis, hyperkeratosis, 
ONJ	with	erythematous	gin‐
giva, SCC, CD, MTX‐associated 
stomatitis)
4 (autoimmune progesterone 
dermatitis, desquamative 
gingivitis in the setting of 







0 1 (cGVHD vs. PAMS/PNP)
Total 27 121
Abbreviations: CD, Crohn disease; cGVHD, chronic graft‐versus‐host disease; EM, erythema 
multiforme; HSV, herpes simplex virus; MMP, mucous membrane pemphigoid; MTX, methotrex‐
ate;	OABD,	oral	autoimmune	bullous	disorder;	OLP,	oral	lichen	planus;	ONJ,	osteonecrosis	of	the	
jaw; PAMS/PNP, paraneoplastic autoimmune multiorgan syndrome/paraneoplastic pemphigus; 
PG, pemphigoid gestationis; PV, pemphigus vulgaris; RAS, recurrent aphthous stomatitis; SCC, 
squamous cell carcinoma; SLE, systemic lupus erythematosus.
TA B L E  3   Definitive diagnoses 
according to clinical suspicion subgroup
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4  | DISCUSSION
As of this writing, at one author's institution, each skin/mucosal 
specimen for DIF is billed at approximately $3,600. As such, we 
sought to determine which patients with findings suspicious for 
OABD are most likely to benefit from the use of DIF. As many 
cases of OLP present with a classic pattern of involvement, we 
hypothesized that in these LS cases, DIF would likely not prove 
to be cost‐effective. Indeed, approximately one third of OLP pa‐
tients in this study showed the typical, well‐described pattern of 
symmetric reticular, erythematous, or ulcerative lesions in the re‐
gion of the buccal mucosa or gingiva, similar to previous reports 
(Eisen, 2002). These cases, in retrospect, did not require DIF to be 
performed.
The diagnostic utility of DIF in establishing the diagnosis of 
OLP has been debated. One prior study has shown that OLP pa‐
tients more commonly show a linear, shaggy, or granular pattern of 
fibrinogen deposition in the basement membrane zone (Rogers & 
Jordon,	1977;	Yamanaka	et	al.,	2017).	However,	these	findings	are	
not specific and have also been observed at a fairly high frequency 
in both pre‐malignant and malignant conditions (Montague, 
Bhattacharyya, Islam, Cohen, & Fitzpatrick, 2015). On the con‐
trary, DIF may aid in distinguishing between the ulcerative pat‐
tern of OLP and chronic ulcerative stomatitis (Ko, Danciu, Fullen, 
& Chan, 2018).
Although our cohort included 11 false negative H&E diagnoses, 
most cases were likely the result of sampling error, perhaps related 
to procedural difficulty in obtaining oral biopsy specimens. Oral 
mucosal biopsies are technically challenging because of extreme 
mucosal fragility in OABD, especially at gingival sites where such 
lesions frequently occur and the mucosa is very thin (Arundhathi, 
Ragunatha, & Mahadeva, 2013; Sultan et al., 2017) Interestingly, 
there were six cases in which DIF was interpreted as negative but 
after clinical follow‐up, re‐biopsy (of oral mucosa or skin), or indirect 
TA B L E  4   H&E false negatives with corresponding DIF and definitive diagnoses
H&E diagnosis DIF diagnosis DIF category Definitive diagnosis
Ulcer with acute and chronic inflamma‐
tion and basal cell degeneration
No immunoreactivity False negative MMP (established by re‐
biopsy of skin with DIF)
Ulcer bed with detached benign squa‐
mous epithelium
Oral mucosa with 4 + C3 and 3 + IgG in a linear array 
along the BMZ consistent with MMP
True positive MMP
Chronic inflammation with rare 
eosinophils
Weak granular C3 and strong linear IgG at the BMZ True positive MMP
Non‐specific acute and chronic 
inflammation
Weak linear IgA and strong linear fibrinogen at BMZ True positive Linear IgA disease
Chronic inflammation Linear basement membrane staining with antibodies to 
IgG and C3
True positive MMP
Mild chronic inflammation 3 + linear C3 deposition and 3 + linear deposition of IgG 
at BMZ, focal granular deposition of IgM
True positive MMP
Acute and chronic inflammation Linear BMZ and intercellular deposition of 3 + IgG 
and 2 + C3
True positive PAMS/PNP
Acute and chronic inflammation Weak granular C3 and fibrin deposition along the BMZ 
and within dermal vessels.
True positive Pemphigoidgestationis
Lichenoid mucositis Partial subepithelial clefting with 1 + focal granular 
C3 and IgG deposition and foci of weak superficial 
epithelial IgG and C3 intercellular staining. Indirect 
immunofluorescence recommended.
Inconclusive PAMS/PNP
No specific pathologic findings 2 + C3 and 4 + IgG in an intercellular pattern True positive PV
Mild chronic inflammation and scat‐
tered eosinophils
Weak to moderate patchy intercellular C3, strong 
intercellular IgG
True positive PV
Abbreviations: BMZ, basement membrane zone; DIF, direct immunofluorescence; MMP, mucous membrane pemphigoid; PAMS/PNP, paraneoplastic 
autoimmune multiorgan syndrome/paraneoplastic pemphigus; PV, pemphigus vulgaris.
TA B L E  5   Sensitivity, specificity, positive predictive value, and 






Sensitivity 0.810 0.807 1
Specificity 0.989 0.980 1
PPV 0.979 0.978 1




Abbreviations: NPV, negative predictive value; PPV, positive predictive 
value.
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immunofluorescence, these cases were revealed to be OABD. Five 
of six cases of false negative DIF biopsies were taken from the gin‐
giva, which was found to be a site yielding low sensitivity in a recent 
report, probably because of such sampling error (Sano et al., 2008; 
Solomon, Helm, Stevens, Neiders, & Kumar, 2007; Sultan et al., 2017). 
However, it has been shown that specimens taken for DIF from non‐
perilesional or distant oral sites rather than perilesional tissue have a 
similar rate of positivity (Sano et al., 2008). Sites that yielded higher 
rates of positivity in this study included floor of mouth, hard palatal 
mucosa, lip mucosa, and ventral tongue, with punch biopsy being a 
more sensitive method than biopsy by scalpel (Sano et al., 2008).
Our results may be specific to our patient population and re‐
ferral pattern; additionally, the retrospective nature of the study 
introduces possible selection bias, possibly with regard to search 
terms used. However, the results indicate that in patients with a low 
clinical suspicion for OABD, it is reasonable and more cost‐effective 
to perform a biopsy for H&E alone in select patients. An alternative 
solution would be to separate a larger biopsy into two fragments or 
harvest two biopsies, one for formalin fixation and routine H&E his‐
topathology, and the other in DIF transfer medium (such as Michel's 
transport medium) that can be stored for several days prior to pro‐
cessing until H&E results are obtained. In this framework, patients 
with histologic features suggestive or suspicious for OABD would 
receive DIF testing of the stored specimen after reporting of H&E 
results. However, if the suspicion for OABD is high, concurrent, up‐
front submission for DIF is recommended, as H&E alone fails to rec‐
ognize a number of cases (Arundhathi et al., 2013; Yih et al., 1998). 
Although DIF is still considered the gold standard for the diagnosis 
of immunobullous disease and is necessary for definitive diagnosis 
(Giurdanella,	Diercks,	Jonkman,	&	Pas,	2016;	“Oral	features	of	mu‐
cocutaneous disorders”, 2003), our analysis indicates that DIF is not 
invariably reliable, and close clinical follow up and sometimes re‐bi‐
opsy may be needed for definitive diagnosis. Furthermore, a high 
index of suspicion warrants repeat DIF testing if routine histologic 
examination is non‐specific or suggestive of OABD.
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